SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : APPI - Advanced Plant Pharmaceuticals Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BARRY ALLEN who wrote (595)9/3/1998 2:27:00 PM
From: BARRY ALLEN  Read Replies (1) of 1263
 
NEWS! GO APPI!

Thursday September 3, 1:36 pm Eastern Time

Company Press Release

Advanced Plant Pharmaceuticals, Inc. APPI Announces It has Received an Initial Purchase Order From Kemin Industries, Inc.

NEW YORK--(BUSINESS WIRE)--Sept. 3, 1998--ADVANCED PLANT PHARMACEUTICALS, INC. (OTC Bulletin Board APPI) announced today that it has received an initial purchase order from Kemin Industries, Inc. for the manufacture of pharmaceutical grade Rosemary pursuant to the Company's patent pending processing technologies.

Pursuant to this initial order from Kemin Industries, the Company will deliver a test batch of Rosemary to be manufactured in accordance with the Company's proprietary whole plant standardizing process. The Company believes that delivery of product meeting Kemin's specifications will lead to ongoing purchase orders for this product and possibly other product offerings made by the Company. Mr. David Lieberman the Company's president said: ''We are experiencing greater interest and reception for the Company's unique proprietary standardizing process from a broader range of nutritional and pharmaceutical Companies.''

Kemin Industries, Inc. produces; Crop Stabilizers, Antioxidants, Deodorants, Enzymes, Flavors, Surfactants, Mold Inhibitors, and Pigments.

APPI is a company that develops innovative plant formulations and technology for clinical application. The Company believes that it has the capability of upgrading any nutritional product currently on the market to pharmaceutical grade. APPI has met FDA nutritional specifications for the marketing of its Lo-Chol in the USA.

--------------------------------------------------------------------------------
Contact:
Advanced Plant Pharmaceuticals, Inc.
Martin Clare 212 402-7878

--------------------------------------------------------------------------------
biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext